We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current B1SX34 market cap is 847.39B. The company's latest EPS is USD 1.2573 and P/E is 78.84.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.73B | 3.86B | 4.12B | 4.21B | 4.56B |
| Operating Income | 599M | 690M | 522M | 712M | 676M |
| Net Income | 505M | 495M | 324M | 469M | 565M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.91B | 11.89B | 12.68B | 14.35B | 16.75B |
| Operating Income | -179M | 984M | 1.7B | 2.4B | 2.6B |
| Net Income | -115M | 985M | 642M | 1.57B | 1.85B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 35.14B | 36.67B | 37.11B | 38.08B | 39.4B |
| Total Liabilities | 15.61B | 16.5B | 16.5B | 17.12B | 17.39B |
| Total Equity | 19.53B | 20.17B | 20.61B | 20.96B | 22B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.78B | 32.23B | 32.47B | 35.14B | 39.4B |
| Total Liabilities | 15.45B | 15.61B | 14.9B | 15.61B | 17.39B |
| Total Equity | 15.33B | 16.62B | 17.57B | 19.53B | 22B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.5B | 164M | 977M | 1.98B | 3.44B |
| Investing | -2.57B | -285M | -556M | -1.98B | -5.69B |
| Financing | 5M | 1.57B | 1.59B | 1.6B | 1.81B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.51B | 1.87B | 1.53B | 2.5B | 3.44B |
| Investing | -411M | -1.6B | -2.01B | -2.57B | -5.69B |
| Financing | 293M | -95M | -548M | 5M | 1.81B |
| Market Cap | 847.39B |
| Price to Earnings Ratio | 78.84 |
| Price to Sales Ratio | 8.72 |
| Price to Cash Ratio | 352.9 |
| Price to Book Ratio | 6.64 |
| Dividend Yield | - |
| Shares Outstanding | 1.47B |
| Average Volume (1 week) | 845 |
| Average Volume (1 Month) | 363 |
| 52 Week Change | 71.82% |
| 52 Week High | 615.11 |
| 52 Week Low | 329.67 |
| Spread (Intraday) | 2.9 (0.51%) |
| Company Name | Boston Scientific Corp. |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bostonscientific.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
